{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:24:17Z","timestamp":1777353857997,"version":"3.51.4"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":242,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jlr.2021.100114","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:56:53Z","timestamp":1630630613000},"page":"100114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7619-7351","authenticated-orcid":false,"given":"Nina H.","family":"Pipalia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Z.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanagaraj","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"al-Motawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian S.J.","family":"Blagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Len","family":"Neckers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Helquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Ory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4396-8866","authenticated-orcid":false,"given":"Frederick R.","family":"Maxfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2021.100114_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/CPJ.0000000000000399","article-title":"Recommendations for the detection and diagnosis of Niemann-Pick disease type C: An update","volume":"7","author":"Patterson","year":"2017","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jlr.2021.100114_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1399-0004.2005.00490.x","article-title":"Identification of 25 new mutations in 40 unrelated Spanish Niemann-Pick type C patients: genotype-phenotype correlations","volume":"68","author":"Fernandez-Valero","year":"2005","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jlr.2021.100114_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/humu.10255","article-title":"Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1","volume":"22","author":"Park","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jlr.2021.100114_bib4","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.1007\/s12035-019-1528-z","article-title":"Niemann-Pick disease type C: Mutation spectrum and novel sequence variations in the human NPC1 gene","volume":"56","author":"Polese-Bonatto","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jlr.2021.100114_bib5","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0929-693X(10)70010-5","article-title":"[Niemann-Pick C disease: history, current research topics, biological and molecular diagnosis]","volume":"17 Suppl 2","author":"Vanier","year":"2010","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.jlr.2021.100114_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-014-9794-4","article-title":"Complex lipid trafficking in Niemann-Pick disease type C","volume":"38","author":"Vanier","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2021.100114_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jlr.2021.100114_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12883-015-0511-1","article-title":"Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database","volume":"15","author":"Imrie","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jlr.2021.100114_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13023-014-0140-6","article-title":"Observational, retrospective study of a large cohort of patients with Niemann-Pick disease type C in the Czech Republic: a surprisingly stable diagnostic rate spanning almost 40 years","volume":"9","author":"Jahnova","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jlr.2021.100114_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-8-12","article-title":"Disease and patient characteristics in NP-C patients: findings from an international disease registry","volume":"8","author":"Patterson","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jlr.2021.100114_bib11","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1074\/jbc.M708735200","article-title":"Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding","volume":"283","author":"Gelsthorpe","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib12","doi-asserted-by":"crossref","first-page":"19714","DOI":"10.1074\/jbc.M114.549915","article-title":"Endoplasmic reticulum-associated degradation of Niemann-Pick C1: evidence for the role of heat shock proteins and identification of lysine residues that accept ubiquitin","volume":"289","author":"Nakasone","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.brainres.2016.03.035","article-title":"Lysosome and endoplasmic reticulum quality control pathways in Niemann-Pick type C disease","volume":"1649","author":"Schultz","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.jlr.2021.100114_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddz215","article-title":"Individualized management of genetic diversity in Niemann-Pick C1 through modulation of the Hsp70 chaperone system","volume":"29","author":"Wang","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jlr.2021.100114_bib15","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1086\/302620","article-title":"Mutations in NPC1 highlight a conserved NPC1-specific cysteine-rich domain","volume":"65","author":"Greer","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jlr.2021.100114_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.277.5323.232","article-title":"Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene","volume":"277","author":"Loftus","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jlr.2021.100114_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.277.5323.228","article-title":"Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis","volume":"277","author":"Carstea","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jlr.2021.100114_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1194\/jlr.M072140","article-title":"Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells","volume":"58","author":"Pipalia","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2021.100114_bib19","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2021.100114_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40263-019-00642-2","article-title":"Long-term neuropsychological outcomes from an open-label Phase I\/IIa trial of 2-hydroxypropyl-\u03b2-cyclodextrins (VTS-270) in Niemann-Pick disease, type C1","volume":"33","author":"Farmer","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jlr.2021.100114_bib21","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1073\/pnas.1014890108","article-title":"Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts","volume":"108","author":"Pipalia","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2021.100114_bib22","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1523\/JNEUROSCI.4173-14.2015","article-title":"A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele","volume":"35","author":"Praggastis","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jlr.2021.100114_bib23","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.bbalip.2019.04.011","article-title":"2-Hydroxypropyl-beta-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease","volume":"1864","author":"Davidson","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jlr.2021.100114_bib24","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1093\/hmg\/dds145","article-title":"Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts","volume":"21","author":"Yu","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jlr.2021.100114_bib25","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.bmcl.2017.04.062","article-title":"Phenanthridin-6-one derivatives as the first class of non-steroidal pharmacological chaperones for Niemann-Pick disease type C1 protein","volume":"27","author":"Fukuda","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jlr.2021.100114_bib26","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1016\/j.bmcl.2014.05.064","article-title":"Structure-activity relationships of oxysterol-derived pharmacological chaperones for Niemann-Pick type C1 protein","volume":"24","author":"Ohgane","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jlr.2021.100114_bib27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2741\/3691","article-title":"HDACi--going through the mechanisms","volume":"16","author":"Wanczyk","year":"2011","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jlr.2021.100114_bib28","doi-asserted-by":"crossref","first-page":"56110","DOI":"10.18632\/oncotarget.18125","article-title":"Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jlr.2021.100114_bib29","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1074\/mcp.M116.064949","article-title":"Quantitative analysis of the proteome response to the histone deacetylase inhibitor (HDACi) vorinostat in Niemann-Pick type C1 disease","volume":"16","author":"Subramanian","year":"2017","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.jlr.2021.100114_bib30","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1158\/1541-7786.MCR-15-0234","article-title":"Maximizing the therapeutic potential of HSP90 inhibitors","volume":"13","author":"Butler","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jlr.2021.100114_bib31","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033951","article-title":"Functional modules of the proteostasis network","volume":"12","author":"Jayaraj","year":"2020","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"10.1016\/j.jlr.2021.100114_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12192-013-0467-2","article-title":"A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo","volume":"19","author":"Cha","year":"2014","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.jlr.2021.100114_bib33","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/hmg\/10.12.1307","article-title":"Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease","volume":"10","author":"Sittler","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jlr.2021.100114_bib34","doi-asserted-by":"crossref","first-page":"355ra118","DOI":"10.1126\/scitranslmed.aad9823","article-title":"Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses","volume":"8","author":"Kirkegaard","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jlr.2021.100114_bib35","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1080\/00397911.2019.1602654","article-title":"The succinct synthesis of AT13387, a clinically relevant Hsp90 inhibitor","volume":"49","author":"Kaur","year":"2019","journal-title":"Synth. Commun."},{"key":"10.1016\/j.jlr.2021.100114_bib36","doi-asserted-by":"crossref","first-page":"19004","DOI":"10.1038\/srep19004","article-title":"CPUY201112, a novel synthetic small-molecule compound and inhibitor of heat shock protein Hsp90, induces p53-mediated apoptosis in MCF-7 cells","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2021.100114_bib37","doi-asserted-by":"crossref","first-page":"116672","DOI":"10.1016\/j.lfs.2019.116672","article-title":"17-DMAG, an Hsp90 inhibitor, ameliorates ovariectomy-induced obesity in rats","volume":"232","author":"Tsai","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.jlr.2021.100114_bib38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000101849","article-title":"Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy","volume":"4","author":"Herbst","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.jlr.2021.100114_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004595","article-title":"Hsp40 couples with the CSPalpha chaperone complex upon induction of the heat shock response","volume":"4","author":"Gibbs","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2021.100114_bib40","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1073\/pnas.73.9.3178","article-title":"Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts","volume":"73","author":"Basu","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jlr.2021.100114_bib41","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/ATVBAHA.109.191882","article-title":"Aggregated LDL in contact with macrophages induces\u00a0local increases in free cholesterol levels that regulate local actin polymerization","volume":"29","author":"Grosheva","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2021.100114_bib42","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jlr.2021.100114_bib43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1194\/jlr.M500388-JLR200","article-title":"Automated microscopy screening for compounds that partially revert cholesterol accumulation in Niemann-Pick C cells","volume":"47","author":"Pipalia","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2021.100114_bib44","doi-asserted-by":"crossref","first-page":"C723","DOI":"10.1152\/ajpcell.00462.2010","article-title":"A practical guide to evaluating colocalization in biological microscopy","volume":"300","author":"Dunn","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jlr.2021.100114_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1083\/jcb.117.2.301","article-title":"Delivery of ligands from sorting endosomes to late endosomes occurs by maturation of sorting endosomes","volume":"117","author":"Dunn","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jlr.2021.100114_bib46","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/hmg\/ddy117","article-title":"High-content screen for modifiers of Niemann-Pick type C disease in patient cells","volume":"27","author":"Pugach","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jlr.2021.100114_bib47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/1878-0261.12054","article-title":"Histone deacetylase activity mediates acquired resistance towards structurally diverse HSP90 inhibitors","volume":"11","author":"Chai","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jlr.2021.100114_bib48","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s12272-012-1101-z","article-title":"Recent updates on the development of ganetespib as a Hsp90 inhibitor","volume":"35","author":"Choi","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jlr.2021.100114_bib49","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1158\/1078-0432.CCR-16-3151","article-title":"Efficacy of onalespib, a long-acting second-generation HSP90 inhibitor, as a single agent and in combination with temozolomide against malignant gliomas","volume":"23","author":"Canella","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jlr.2021.100114_bib50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/pbc.23154","article-title":"Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing program","volume":"59","author":"Kang","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.jlr.2021.100114_bib51","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1021\/jm100060b","article-title":"Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydrois oindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug design","volume":"53","author":"Woodhead","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41598-017-00143-6","article-title":"Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2021.100114_bib53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/acs.jmedchem.8b01085","article-title":"Discovery of 3-ethyl-4-(3-isopropyl-4-(4-(1-methyl-1 H-pyrazol-4-yl)-1 H-imidazole-1-yl)-1 H-pyrazolo[3,4- b]pyridin-1-yl)benzamide (TAS-116) as a potent, selective, and orally available HSP90 inhibitor","volume":"62","author":"Uno","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib54","doi-asserted-by":"crossref","first-page":"26130","DOI":"10.18632\/oncotarget.25452","article-title":"Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activity","volume":"9","author":"Chai","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jlr.2021.100114_bib55","doi-asserted-by":"crossref","first-page":"107747","DOI":"10.1016\/j.pharmthera.2020.107747","article-title":"Assay design and development strategies for finding Hsp90 inhibitors and their role in human diseases","volume":"221","author":"Banerjee","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jlr.2021.100114_bib56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejmech.2014.03.061","article-title":"Identification and optimization of novel Hsp90 inhibitors with tetrahydropyrido[4,3-d]pyrimidines core through shape-based screening","volume":"79","author":"Sun","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib57","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/acs.jmedchem.9b01659","article-title":"Discovery and optimization of small molecules targeting the protein-protein interaction of heat shock protein 90 (Hsp90) and cell division cycle 37 as orally active inhibitors for the treatment of colorectal cancer","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib58","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejmech.2019.02.014","article-title":"Design, synthesis, and biological evaluation of truncated deguelin derivatives as Hsp90 inhibitors","volume":"167","author":"Yao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib59","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1021\/jm400619b","article-title":"Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series","volume":"56","author":"Taldone","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib60","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1046\/j.1471-4159.2002.01220.x","article-title":"Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann-Pick C1-deficient neurons","volume":"83","author":"Karten","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jlr.2021.100114_bib61","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1073\/pnas.0914309107","article-title":"Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells","volume":"107","author":"Rosenbaum","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jlr.2021.100114_bib62","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1074\/mcp.M114.045609","article-title":"Quantitative proteomics of human fibroblasts with I1061T mutation in Niemann-Pick C1 (NPC1) protein provides insights into the disease pathogenesis","volume":"14","author":"Rauniyar","year":"2015","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.jlr.2021.100114_bib63","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1074\/jbc.RA119.010524","article-title":"Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid","volume":"295","author":"Subramanian","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib64","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1038\/s41467-019-12969-x","article-title":"Quantitating the epigenetic transformation contributing to cholesterol homeostasis using Gaussian process","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"issue":"Pt 8","key":"10.1016\/j.jlr.2021.100114_bib65","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1242\/jcs.107.8.2177","article-title":"Quantification of low density lipoprotein and transferrin endocytic sorting HEp2 cells using confocal microscopy","volume":"107","author":"Ghosh","year":"1994","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jlr.2021.100114_bib66","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1152\/physrev.1997.77.3.759","article-title":"Endocytosis","volume":"77","author":"Mukherjee","year":"1997","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jlr.2021.100114_bib67","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1074\/jbc.M111.294801","article-title":"A screen for enhancers of clearance identifies huntingtin as a heat shock protein 90 (Hsp90) client protein","volume":"287","author":"Baldo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib68","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12192-009-0165-2","article-title":"A new feature of the stress response: increase in endocytosis mediated by Hsp70","volume":"15","author":"Vega","year":"2010","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.jlr.2021.100114_bib69","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.tranon.2014.08.001","article-title":"Comparative study of 17-AAG and NVP-AUY922 in pancreatic and colorectal cancer cells: are there common determinants of sensitivity?","volume":"7","author":"Mayor-Lopez","year":"2014","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jlr.2021.100114_bib70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1158\/1535-7163.MCT-14-0219","article-title":"TAS-116, a highly selective inhibitor of heat shock protein 90alpha and beta, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models","volume":"14","author":"Ohkubo","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jlr.2021.100114_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molcel.2007.10.007","article-title":"A Grp on the Hsp90 mechanism","volume":"28","author":"Richter","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jlr.2021.100114_bib72","doi-asserted-by":"crossref","first-page":"15775","DOI":"10.1002\/chem.201703398","article-title":"Second generation Grp94-selective inhibitors provide opportunities for the inhibition of metastatic cancer","volume":"23","author":"Crowley","year":"2017","journal-title":"Chemistry"},{"key":"10.1016\/j.jlr.2021.100114_bib73","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1021\/acs.jmedchem.6b00085","article-title":"Development of glucose regulated protein 94-selective inhibitors based on the BnIm and Radamide scaffold","volume":"59","author":"Crowley","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib74","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1021\/acsmedchemlett.7b00193","article-title":"Resorcinol-based Grp94-selective inhibitors","volume":"8","author":"Khandelwal","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jlr.2021.100114_bib75","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41467-017-02013-1","article-title":"Structure-guided design of an Hsp90beta N-terminal isoform-selective inhibitor","volume":"9","author":"Khandelwal","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2021.100114_bib76","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1021\/acschembio.6b00747","article-title":"Transformation of the non-selective aminocyclohexanol-based Hsp90 inhibitor into a Grp94-seletive scaffold","volume":"12","author":"Mishra","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jlr.2021.100114_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12428","article-title":"Efficacy and safety of arimoclomol in Niemann-Pick disease type C: results from a double-blind, randomised, placebo-controlled, multinational phase 2\/3 trial of a novel treatment","author":"Mengel","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jlr.2021.100114_bib78","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1146\/annurev-biochem-060809-095203","article-title":"Regulation of HSF1 function in the heat stress response: implications in aging and disease","volume":"80","author":"Anckar","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jlr.2021.100114_bib79","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12192-016-0708-2","article-title":"Induction of heat shock proteins in differentiated human neuronal cells following co-application of celastrol and arimoclomol","volume":"21","author":"Deane","year":"2016","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.jlr.2021.100114_bib80","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.celrep.2014.09.056","article-title":"A direct regulatory interaction between chaperonin TRiC and stress-responsive transcription factor HSF1","volume":"9","author":"Neef","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.jlr.2021.100114_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000291","article-title":"Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease","volume":"8","author":"Neef","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jlr.2021.100114_bib82","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature08710","article-title":"Hsp70 stabilizes lysosomes and reverts Niemann-Pick\u00a0disease-associated lysosomal pathology","volume":"463","author":"Kirkegaard","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2021.100114_bib83","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1158\/0008-5472.CAN-17-3728","article-title":"Targeting the Hsp40\/Hsp70 chaperone axis as a novel strategy to treat castration-resistant prostate cancer","volume":"78","author":"Moses","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.jlr.2021.100114_bib84","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1021\/acs.jmedchem.8b00583","article-title":"Exploration of benzothiazole rhodacyanines as allosteric inhibitors of protein-protein interactions with heat shock protein 70 (Hsp70)","volume":"61","author":"Shao","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib85","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1038\/s41598-018-25404-w","article-title":"HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation","volume":"8","author":"Kijima","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2021.100114_bib86","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm1097-1150","article-title":"Bimoclomol: a nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects","volume":"3","author":"Vigh","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.jlr.2021.100114_bib87","doi-asserted-by":"crossref","first-page":"9794","DOI":"10.1039\/C7OB02578E","article-title":"Regioselective and enantiospecific synthesis of the HSP co-inducer arimoclomol from chiral glycidyl derivatives","volume":"15","author":"Atkinson","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jlr.2021.100114_bib88","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejca.2019.08.009","article-title":"Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial","volume":"121","author":"Doi","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jlr.2021.100114_bib89","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1535-7163.MCT-18-0831","article-title":"First-in-Human Phase I Study of an oral HSP90 Inhibitor, TAS-116, in patients with advanced solid tumors","volume":"18","author":"Shimomura","year":"2019","journal-title":"Mol. Cancer Ther."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227521000961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227521000961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T05:04:55Z","timestamp":1645074295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227521000961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":89,"alternative-id":["S0022227521000961"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2021.100114","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.22.440982","asserted-by":"object"}]},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2021.100114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100114"}}